Top 100 Healthcare Leaders 2023
Proud to announce that Dr. Shamsheer Vayalil, our Founder and Chairman, is listed as one of the top 10 among the Middle East’s top 100 healthcare leaders. The list by Forbes Middle East recognizes his influential role within the region’s healthcare ecosystem. We are privileged to serve the community under his visionary leadership that aims to transform the healthcare landscape in the region.
Read Full Story: ForbesMiddleEast
Husband in Abu Dhabi gives gift of life to wife by donating kidney
Maria Theresa Coronel is recovering in hospital and will be discharged in a couple of days In a true love story, a woman’s life has been saved by her husband’s kidney donation. Maria Theresa Coronel, 37, underwent painful dialysis for six years, before her husband Frederick Valiente, 38, discovered he was the match she needed for the life-saving operation. They have been married for nine years and have a son, five, and a daughter, seven. Ms Coronel, from the Philippines, who works as a sales executive, developed pre-eclampsia when she was pregnant. The condition can cause high blood pressure, protein in urine and can also affect the kidneys, which happened in Ms Coronel’s case. She received twice-weekly dialysis but a kidney transplant was the only permanent solution. Dialysis treatment involves a tube being attached to the patient’s arm via a needle that extracts blood into a filtration machine, which replicates the job of a healthy, fully functioning kidney.
“I wanted my wife to be well,” said Mr Valiente. “I couldn’t bear to see her suffering and what dialysis was doing to her body.”
As well as Mr Valiente, Ms Coronel’s niece was checked for compatibility — but her husband was found to be a good match.
“There was no question about it,” he said.
“I love my wife and would do anything for her. I’m glad I was able to help her in some way to bring our family back to normal life again by donating one of my kidneys.”
Ms Coronel said their love story started in the Philippines in 2010 and they moved together to UAE in 2015.
“He used to be my boyfriend many years ago and then I came to the UAE and we each went our own way,” she said.
“Only when I started work I found out that he was working at the same place where I was and we picked it up from there and have been together since then.
“He is the love of my life. I had his heart and now I have his kidney.”
The transplant took place at Burjeel Medical City in the capital on March 2.
“Maria’s family members were informed that a blood-group compatible donor from the family who wished to donate voluntarily could come for medical evaluation,” said Dr Venkat Vellanki, director of transplant nephrology at Burjeel.
“Maria’s niece and husband volunteered for initial evaluation and her husband, who had a compatible blood group with her, was found to be a suitable match.”
Transplant surgeon Dr Rehan Saif said: “Both surgeries took place simultaneously in a staggered fashion to keep the ischemia time — time that the kidney remains outside the body between removal and transplant — to a minimum.”
He said the operation involved a “minimally invasive method”, a kind of keyhole surgery using a 3D technology camera. Doctors say the husband has been discharged and the wife is recovering well in the hospital. Ms Coronel was moved out of the intensive care unit to the ward and will be able to go home in a couple of days.
Read Full Story: TheNationalNews | GulfToday | KhaleejTimes | GulfNews
Frontline Heroes Office shares inspirational stories of sacrifices made by women
ABU DHABI, 8th March, 2023 (WAM) — The Frontline Heroes Office (FHO) affirmed that the UAE leadership is keen to honour and empower women, and support their participation in all of the nation’s vital fields and sectors.
To mark the occasion of International Women’s Day, the FHO thanks the UAE’s wise leadership for its support and guidance, and leading the way when it comes to adopting women-focused initiatives and addressing the issues they face.
FHO indicated that the UAE adopted the approach of empowering women followed by the late Sheikh Zayed bin Sultan Al Nahyan, who said, “Women are not only half of society in terms of numbers, but also in terms of their role in preparing and raising future generations.”
FHO stated that women have proved their worth through their distinguished capabilities, and the farsightedness of the wise leadership in their abilities, setting the finest example in raising generations qualified to contribute to building a sustainable future for all members of society, and have made the highest sacrifices on the front lines, especially as the Covid-19 virus phase swept the world.
The office added that womwn have borne enormous burdens while balancing their work with their concern for their families, and proven their competence in managing crises inside and outside the home. Women were frontline heroes for their families before working on the front lines in the health sector and in the fields of crisis and disaster management, and their experiences at home fully prepared the women for the transition from raising their children to working as frontline heroes.
In a meeting with some of the most prominent women to talk about the challenges they faced during the period of the pandemic’s spread, Dr. Rania Zeineldin, Chest Diseases Specialist at Burjeel Hospital in Abu Dhabi, said, “The Covid-19 pandemic posed a great challenge for women compared to other members of society. It was about finding a balance between our work, our family and social responsibilities mixed with fear for our family members’s safety, and our keenness to avoid infecting them, especially the elderly.
She added, “On a practical level, the unprecedented increase in the number of illnesses had a great impact on our psychological state, especially at the beginning of 2020, given my work as a chest doctor, but my great faith in my abilities and the huge support from all sides helped me overcome this crisis. This stage went smoothly and safely, and I had the honor to be one of the frontline heroes, maintaining a continuous presence on the front lines to confront the virus.”
“My fear for myself or my family did not stop me from carrying out my duty by visiting every patient, following up on their condition, and raising their spirits to help them confront the virus, as the psychological factor at that time had a great impact in helping patients cope with their illness. We felt we had a moral role in encouraging and raising the spirits of our fellow doctors, especially in the early stages of the pandemic, as we did not have much information about the ways it spread and how to treat it,” she added.
“After that, and the provision of treatment plans created by the concerned UAE health authorities, in addition to continuous and effective communication with specialized support groups to exchange views on how to combat the virus, had a prominent role in providing us with reassurance, and helped us reach the recovery stage across all government hospitals, as well the ability to successfully eradicate the virus.”
Dr. Rania is proud of be one of the frontline heroes, and part of the pioneering health sector’s renaissance and development in the country. She confirmed she tries to balance her work with carrying out her family responsibilities, saying she devotes part of her time to caring for her children and husband, in addition to setting aside time for them all to enjoy as a family.
Sheela Joyce, Charge Nurse at Burjeel Medical City, said that she takes her role as a nurse seriously and is keen to provide any healthcare support she can for patients in the hospital, even though it poses a great challenge for her and her family, especially so during Covid-19, when she was keen at that time not to infect anyone at home.
“My family has always been a source of support for me as one of the frontline heroes, and it was a challenge to achieve a balance between my work and my family. Thankfully, the state spared no effort to provide an appropriate healthy environment in order to keep everyone safe, making sure that the virus does not spread, and I had my supportive family members waiting at home,” she added.
Read Full Story: wam
Hamdan bin Zayed visits victims of Syrian earthquake receiving treatment in UAE hospitals under Mother of the Nation initiative
His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of Emirates Red Crescent, has visited victims of Syrian earthquake receiving medical treatment in UAE’s hospitals as part of an initiative from Her Highness Sheikha Fatima bint Mubarak, Chairwoman of the General Women’s Union, President of the Supreme Council for Motherhood and Childhood, Supreme Chairwoman of the Family Development Foundation, Mother of the Nation, and Honourary President of Emirates Red Crescent, who directed the treatment of Syrian earthquake victims at UAE hospitals.
His Highness also directed to provide the victims with the highest levels of healthcare, reaffirming UAE’s continued efforts within Bridges of Goodness campaign launched by the UAE and its commitment to support victims of humanitarian disasters and crises worldwide.
Read Full Story: abudhabimediaoffice | wam | NationalNews | GulfNews
DoH announces winners of Healthcare Research and Innovation Grant
ABU DHABI, 24th February, 2023 (WAM) — The Department of Health – Abu Dhabi (DoH), which regulates the healthcare sector in the emirate, has announced the winners of its Healthcare Research and Innovation Grant. The grant, launched in September 2022, received over 70 complete submissions, and the top eight were awarded a monetary prize at the awards ceremony during DoH’s Innovation Week at the Department’s headquarters.
Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi handed the awards to the winners, in the presence of Dr. Rashed Al Suwaidi, Executive Director of Healthcare Workforce Planning at DoH and Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at DoH.
The winners included six research submissions from Burjeel Medical City, Tawam Hospital, SEHA, Sheikh Shakhbout Medical City Abu Dhabi (SSMC), and Cleveland Clinic Abu Dhabi. In addition, two innovations/proof of concept (PoCs) from SSMC and SEHA were also awarded. As part of the award, the winners will have the opportunity to conduct clinical trials and commercialise their ideas with the support of DoH’s Research and Innovation Centre and other leading partners from across the emirate’s healthcare sector.
Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at DoH, said that the Grant reflects Abu Dhabi’s dedication and capabilities in the field of healthcare, and reinforces its position as a leading destination for life sciences and innovation. She added that DoH remains committed to enabling and supporting research across all dimensions of healthcare, including Artificial Intelligence (AI), medical devices, and digital platforms.
The winning proposals covered a range of topics, including genetic and hematologic determinants of outcomes in β-thalassemia, multimodal screening for mild cognitive impairment and dementia, and a randomised trial of integrating whole genome sequencing into the management of hypercholesterolemia in Emiratis.
The Grant is part of DoH’s continuous efforts to leverage science and technology in order to establish a knowledge-based economy and support the emirate’s endeavours in positioning itself as a leading life science hub in the region. Its aim is to encourage a culture of research and innovation among healthcare professionals, promote clinical research, increase the amount of intellectual property (IP) generated in Abu Dhabi, and leverage advanced platforms for clinical research in the emirate.
DoH’s Innovation Week 2023 saw the participation of many entities from the wider healthcare ecosystem in Abu Dhabi, including a demo day held in the Department’s virtual office in the Abu Dhabi Life Sciences Hub in the Metaverse, bringing together start-ups and investors in the same virtual space.
Read Full Story: wam
Burjeel Holdings delivers record FY22 results with net profit up 52% to AED 355 million
- IPO proceeds of AED2.2bn drives net debt reduction to AED1.1bn
- Revenue of AED 3.92 billion up 17% y-o-y with EBITDA of AED 878 million up 13%
- Strong financial position with Net Debt/EBITDA* at 1.5x at the end of the period
- Delivering on our strategy to grow patient yields and drive utilization across our network
- Entry into Saudi Arabia underway through joint venture with Leejam Sports
- Expected to deliver robust growth in 2023 with group revenue expected to grow organically in the high-teens and EBITDA margins to improve to at least 2021 levels
- Various strategic growth opportunities, including M&A, under consideration
Abu Dhabi, United Arab Emirates, 10 February 2023: Burjeel Holdings PJSC (“Burjeel” or “the Group”), a leading Healthcare Services Provider in the UAE and MENA listed on the Abu Dhabi Securities Exchange (“ADX”) (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced its preliminary financial results for the twelve-month and three-month period ended 31 December 2022.
- Net Profit of AED 355 million up 52% from the prior year, demonstrating the Group’s ability to deliver on its yield enhancement strategy
- Revenue of AED 3.92 billion, up 17% YoY, driven by 125% growth at our flagship hospital Burjeel Medical City (BMC)
- EBITDA of AED 878 million, up 13% YoY, with EBITDA margin stable at 22%. Benefitted from strong BMC EBITDA
- Hospital patient footfall increased by 15%, reflecting the Group’s ability to execute on its strategy of elevating asset utilization. Outpatient visits totaled more than 5.4 million in the FY 2022 period
- Burjeel Medical City ramp up continued, with revenue increasing by 125%, driven by increased utilization with total patients nearly tripling and complex specialties elevating average realized revenue (ARR)
- Improved financial position with Net Debt/ EBITDA* of 1.5x at the end of the period, following landmark IPO on AD
Dr Shamsheer Vayalil, Chairman of Burjeel Holdings, commented:
“Our full year results are a testament to the dedication of our people and their commitment to our vision of ensuring quality healthcare across UAE and Oman. 2022 was a milestone year for Burjeel Holdings, having welcomed new shareholders through our listing on ADX and expanded our offering, particularly in the provision of highly specialized and complex care in our core markets. This momentum continued in 2023, with the announcement of our joint venture with Leejam Sports to jointly establish and operate a network of physiotherapy, rehabilitation and wellness centers in Leejam clubs across KSA. With record earnings and a robust balance sheet in place following our IPO, the Group is well positioned to accelerate growth, by deepening expertise in complex care, driving expansion into new markets and elevating utilization and patient yield.”
John Sunil, Chief Executive Officer of Burjeel Holdings, added:
“I’m immensely proud of our performance in 2022 and our continued focus on delivering advanced, yield-enhancing super specialty medicine, and robust utilization improvement across our network. We continued to invest in our ability to deliver complex care and cemented our position as a referral hub in the UAE, as we added world-class talent to our teams, particularly at Burjeel Medical City, our flagship and rapidly growing asset. Our focus on the provision of high-quality complex care is a crucial part of the strategy we presented during our IPO to propel growth by increasing patient yields and drive utilization. The positive performance we delivered in 2022 reflects the successful execution of this strategy and we expect to maintain this momentum in 2023 with strong revenue and margin growth.”
Record Group Revenue, EBITDA; Net Profit up 52%
Burjeel Holdings reported a record performance in FY 2022. Revenue for FY 2022 was AED 3.92 billion, an increase of 17% year-on-year, driven by utilization gains and improved patient yields which were enabled by the Group’s focus on providing high-value complex care in both the Hospitals and Medical Centers segments, where revenues increased by 18% and 10% respectively.
Group EBITDA increased by 13% year-on-year to AED 878 million in FY 2022, delivered at a stable margin of 22.4%. Significant efficiency gains were delivered through the continued ramp up of Burjeel’s centralized laboratory, offset by a proportional increase in manpower costs due to investment made in the recruitment of highly-specialized surgeons and physicians, particularly at Burjeel Medical City, to roll out new services and offerings. These additions greatly enhance Burjeel’s capabilities and will drive further expansion of patient yields and margin improvement as volumes ramp up.
Net Profit in FY 2022 increased by 52% to AED 355 million year-on-year, as a result of the Group’s focus on providing highly specialized complex procedures supporting higher Average Realized Revenue (ARR). ARR, which increases with the complexity of care provided, represents the average revenue per patient and is a major contributor to patient yield.
Overall Group patient footfall increased by 15%. Hospital inpatient footfall increased by 17%, outpacing outpatient footfall growth of 15%, reflecting the Group’s strategic focus on complex inpatient treatments. Both inpatient and outpatient growth was driven by the ramp up of growth assets and the addition of new services.
BMC posts triple-digit growth; drives Hospital segment growth
Revenue from the Hospitals segment, which made up 88% of the Group’s total revenue in the period, increased 18% YoY to AED 3.47 billion driven by strong growth at Burjeel Medical City and the Group’s other larger Burjeel-branded hospitals, as they enhanced their specialty service mix and delivered high-value surgeries including bone marrow and kidney transplants. EBITDA in the Hospitals segment increased by 15% to AED 743 million, with margin declining slightly to 21% (FY2021: 22%), as the Group continue to investment in new service offerings through the hiring of industry leading practitioners in its Complex Cases unit at Burjeel Medical City (BMC). Investment in specialist talent is enabling the unit’s expansion and is expected to drive sustained margin improvement. Excluding BMC, EBITDA margin was stable at 24%
Burjeel’s flagship hospital asset, Burjeel Medical City (BMC), delivered exceptionally strong growth in the FY 2022 period, with revenue increasing by 125% to AED 741 million, as total patients treated nearly tripled YoY. Inpatient bed occupancy at BMC remained stable at 34% and outpatient capacity utilization increased to 29% from 16%. Boasting more than 50 specialities across 1.2 million square feet and now the largest private hospital in the UAE, BMC contributed 20% of the Group’s total Hospitals segment revenue in the full year period.
Operationally, BMC remains focused on super specialty care, including oncology, organ transplants and paediatrics. Complex life-changing and life-saving surgeries provide significant yield for the Group while also positioning the Group to benefit from regional and international inbound medical tourism.
The Medical Centers segment,which accounted for 10% of the Group’s revenues during the period, increased to AED 381 million (FY2021: AED 347 million), reflecting increasing footfall across the Group’s primary care network. Burjeel Holding’s group structure enables effective resource allocation across each of its locations, enabling it to capture patient volume and enable utilization growth. Consequently, EBITDA in the segment during the year increased 22% to AED 113 million, with robust cost management supporting EBITDA margin expansion from 27% in 2021 to 30% in 2022.
Robust balance sheet following IPO
In a year of historic milestones, Burjeel Holdings completed a landmark IPO on the Abu Dhabi Securities Exchange (ADX) in 2022, which saw AED 2.2 billion of liquidity injected into the business, which has significantly deleveraged the balance sheet and unlocked an exciting new pathway for strategic development across new markets, new technologies and new speciality patient provision.
Burjeel ended FY 2022 with Group Net Debt of AED 1.11 billion or 1.5x Net Debt/EBITDA*, placing the group in a strong position and giving it the ability to capitalize on potential growth opportunities, including its recently announced move into KSA.
Expansion into KSA and robust UAE growth
Post-period, on 6 February, 2023, Burjeel announced the formation of a joint venture with Leejam Sports Company JSC, the owner and operator of ‘Fitness Time’ branded fitness centers in KSA and MENA and the largest operator of fitness centers in the GCC region. The MoU will see Burjeel Holdings and Leejam jointly establish and operate a network of physiotherapy, rehabilitation and wellness centers in Leejam clubs across KSA. The venture follows Burjeel’s signing of a Memorandum of Understanding with the Kingdom of Saudi Arabia’s Ministry of Investments which will see Burjeel seek opportunities to invest up to $1 billion in KSA by 2030.
Outlook and dividend
Burjeel expects to continue to deliver robust growth as it executes on the strategy communicated during its IPO. The Group is focused on delivering organic growth by leveraging its high-quality asset base, consisting largely of growth assets with significant utilization headroom. Delivering higher average patient yields through continued investment in complex care remains a priority. The Group’s outlook is bolstered by strong economic growth and supportive demographic trends in its key markets.
The Group continues to actively explore expansion opportunities in the GCC and Africa regions, specialty medical partnerships within its existing asset base and capex-lite operations and management opportunities. With a significantly deleveraged balance sheet and ample liquidity, the group is in a strong position to capitalize on potential acquisition opportunities that are supportive of the group’s overall strategy.
2023 Guidance
- Group revenue is expected to grow organically in the high-teens
- BMC revenue expected to grow more than 1.5x
- EBITDA margin expected to improve to at least 2021 levels
- BMC EBITDA margin expected to improve to mid-high teens
- Maintenance CAPEX expected to be approximately 2.5% of revenue
- The Group may deploy Growth CAPEX (including M&A) funded through a mix of debt and equity.
- Net leverage (Net Debt/ EBITDA*) of less than 2.5x to be maintained
Dividend
As stated at the time of its IPO, Burjeel Holdings intends to pay cash dividends from 2023 onwards, on the expected basis of a pay-out ratio of 40% to 70% of net income, dependent on the required investment for additional growth plans.
PRELIMINARY FINANCIAL RESULTS OVERVIEW
(FY 2022 = 12 months to 31 December 2022)
| AED millions | FY 2022 | FY 2021 | Change% |
| Revenue | 3,924 | 3,351 | 17 |
| EBITDA | 878 | 779 | 13 |
| EBITDA Margin % | 22.4 | 23.3 | (0.9)bp |
| Net Profit for the Period | 355 | 234 | 52 |
| Net Profit Margin % | 9.0 | 7.0 | 2.0bp |
| AED millions | FY 2022 | FY 2021 | Change% |
| Interest Bearing Loans and Borrowings | 1,261 | 3,299 | (61) |
| Net Debt | 1,113 | 3,165 | (65) |
Results by Operating Segments
| Revenue (AED millions) | FY 2022 | FY 2021 | Change% |
| Hospitals | 3,469 | 2,942 | 18 |
| Medical Centers | 381 | 347 | 10 |
| Pharmacies | 65 | 58 | 12 |
| Other | 9 | 4 | 129 |
| Total Revenue | 3,942 | 3,351 | 17 |
| EBITDA (AED millions) | FY 2022 | FY 2021 | Change% |
| Hospitals | 743 | 647 | 15 |
| Medical Centers | 113 | 92 | 22 |
| Pharmacies | 5 | 5 | 8 |
| Other | 17 | 35 | (52) |
| Total EBITDA | 878 | 779 | 13 |
About Burjeel Holdings
Founded in 2007, Burjeel Holdings is one of the leading private healthcare services providers in the MENA region. With a network of 61 assets, including 16 hospitals and 23 medical centers, as well as pharmacies and other allied services, the group provides the highest standard of patient care in the region. Burjeel Holdings’ brands include Burjeel Hospitals, Medeor Hospitals, LLH Hospitals, Lifecare Hospitals, and Tajmeel. It has 12 JCI-accredited facilities, with a total 1,660 patient beds across its operations in UAE and Oman, and holds a leading position in the UAE. The Group has comprehensive cancer care facilities in the UAE, and is the country’s leading mother and child care provider.
Contacts
| Media: Stephen Smith SVP – Teneo burjeelholdings@teneo.com M: +971 58 546 1588 | Investor Relations: Chetan Sehgal Head of Investor Relations – Burjeel Holdings ir@burjeelholdings.com M: +971 56 682 0515 |
Baby girl undergoes bone marrow transplant from sister, 8, in Abu Dhabi
Doctors at Burjeel Medical City perform surgery on little Afeefa after finding sibling’s stem cells match
Doctors in Abu Dhabi have saved the life of a nine-month-old baby girl battling a type of cancer that affected her blood and bone marrow. Afeefa Zahra Muhammad Iqbal was suffering acute lymphoblastic leukaemia. She underwent surgery at Burjeel Medical City after it was found that her blood cells were a match with her sister Nazia, 8. The girls’ Pakistani parents Muhammad Iqbal and Batool Zahra, UAE residents for the past 10 years, said their daughter was only three months old when she started to experience prolonged fever and look pale. After a blood test showed abnormalities, the couple took her to the hospital, where she was diagnosed with acute lymphoblastic leukaemia, which can progress quickly without treatment.
“Acute lymphoblastic leukaemia is one of the common cancers in children, but it needs to be treated aggressively,” said Dr Zainul Aabideen, an oncologist at Burjeel Medical City.
“The advanced genetic test revealed that a high risk of a genetic mutation was driving this leukaemia. As per the international protocol, the only chance to cure her disease was through bone marrow transplantation,” said Dr Aabideen. Doctors identified Nazia as a matching donor, and the third grader was more than happy to help her sister.
“I was sad when the doctors told me my little sister was very sick,” said Nazia.
“I felt happy when my parents told me I could help her get better.
“I was a brave girl, and was not afraid. Afeefa is like my twin sister now.”
The highly advanced bone marrow transplant was conducted on December 1. Afeefa was then kept under strict medical attention to monitor her body’s response to the new cells.
In the days after the procedure, she experienced complications including seizures and infections in her bloodstream but they were successfully managed by the medical team looking after her. Her health and prognosis improved steadily. Afeefa’s parents said their entire life was changed by the successful surgery.
“We now feel like a huge struggle has been over after months of suffering and pain,” said Mr Iqbal.
“I also want to mention my wife, who observed our child round the clock and alerted the medical team even if there was the slightest change in her.
“Her commitment to Afeefa has also played a part in the healing process.”
Prof Humaid Al Shamsi, a consultant at Burjeel, said the team that treated Afeefa were satisfied that she could now return to the care of her family.
“The entire team at Burjeel Medical City is thrilled that baby Afeefa has overcome all odds and is now finally discharged home,” he said.
“The success of the bone marrow procedure in a patient so young offers hope to more children in need of such care. The procedure demonstrates our capabilities and expertise in bone marrow transplant. We are proud of this new milestone.”
Read Full Story: TheNationalNews | GulfNews | GulfToday | ThePrint | UrduPoint
Burjeel Holdings announces creation of new joint venture with Leejam, marking its entry into the Kingdom of Saudi Arabia
The joint venture will see Burjeel and Leejam jointly establish and operate more than 60 clinics across KSA, including comprehensive rehabilitation and sports medicine facilities in KSA’s main centers.
Abu Dhabi, United Arab Emirates, 06 February 2023: UAE-headquartered Burjeel Holdings PJSC (“Burjeel”), a leading ADX-listed Healthcare Services Provider with over 16 hospitals and 23 medical centers in MENA, today announced the signing of a Memorandum of Understanding (“MoU”) to create a joint venture with Leejam Sports Company JSC (“Leejam”), the owner and operator of 155 ‘Fitness Time’ branded fitness centers in Saudi Arabia and the UAE, and the largest operator of fitness centers in the MENA region. The MOU was signed at the Ministry of Investment of Saudi Arabia headquarters in Riyadh.
The MoU will see Burjeel Holdings and Leejam jointly establish and operate a network of more than 60 physiotherapy, rehabilitation and wellness centers in Leejam clubs across the Kingdom, including comprehensive rehabilitation and sports medicine facilities in KSA’s main centers. The centers will offer physiotherapy, restoration, and wellness services including vitamin infusion, oxychambers and cryotherapy, as well as complementary medicine services including Ayurveda and Naturopathy, with a particular focus on sports medicine and advanced rehabilitation treatments. It will also provide expert medical services for pain, musculoskeletal, and neurological problems. The joint venture is supported by the Saudi Ministry of Sport, as it continues to promote initiatives aimed at improving and developing the sports environment in the Kingdom.
The newly created joint venture will initially open six centers in the next quarter in Riyadh city, expanding its services across the Leejam network in KSA over the next 12-18 months.
Commenting on the announcement, Dr. Shamsheer Vayalil, Founder and Chairman, Burjeel Holdings, said: “Our collaboration with Leejam to provide high-quality services in rehabilitation and sports medicine is significant as we commence operations in KSA, renowned for its love of sports, and especially football. Professional and recreational athletes of all levels and passionate youngsters stand to benefit from comprehensive care, ranging from prevention to rehabilitation, which will be tailored to their specific needs. Such offerings will create a world-class support system enabling these sportspersons to elevate their performance. We are also committed to supporting the transformative Vision 2030, which acknowledges the importance of partnerships with the private sector to promote sports for wellbeing.”
Ali Al Sagri, Chairman, Leejam Sports, added: “The MOU confirms the company’s commitment to harnessing the full extent of its capabilities to raise the level of healthcare and physical fitness, and to achieve a healthier life for body and mind. Our partnership with Burjeel Holdings, a leader in the field of healthcare services, ensures integrated sports medicine services of the best international standards.”
The joint venture partnership will be operated through a newly formed company established under Saudi law and in which Burjeel and Leejam will each hold an equal 50% shareholding.
Burjeel Holdings is also in advanced discussions to operate and maintain a number of hospital assets in the Kingdom, as well as separate potential partnerships in the delivery of niche, specialized medical care.
In addition, Burjeel Holdings’ sector-leading orthopedics practice recently announced the launch of The Paley Middle East Clinic, a partnership with renowned deformity-correction and limb lengthening expert Dr. Dror Paley. The clinic, located in Burjeel Medical City, Abu Dhabi, is the first Paley Clinic in the Middle East and will bolster Burjeel Holdings’ orthopedic and neurosurgical care practice.
—–Ends—–
About Burjeel Holdings
Founded in 2007, Burjeel Holdings is one of the leading private healthcare services providers in the MENA region. With a network of 61 assets, including 16 hospitals and 23 medical centers, as well as pharmacies and other allied services, the group provides the highest standard of patient care in the region. Burjeel Holdings’ brands include Burjeel Hospitals, Medeor Hospitals, LLH Hospitals, Lifecare Hospitals, and Tajmeel. It has 12 JCI-accredited facilities, with a total 1,660 patient beds across its operations in UAE and Oman and holds a leading position in the UAE. The Group has comprehensive cancer care facilities in the UAE and is the country’s leading mother and childcare provider.
About Leejam Sports
Leejam Sports company is the only publicly traded fitness company in the MENA region, Fitness Time is a full-service health and fitness provider.
All Fitness Time centers are equipped with technologically advanced equipment handpicked from around the world. We have invested heavily in providing our members with the highest standards in sports, recreation and fitness. We complement our top-of-the-line equipment with highly qualified and professionally certified staff to provide our members with an exceptional experience. Fitness Time strives to provide the best sports and fitness services through our growing network of facilities across the Middle East and North Africa. We believe health goals can be achieved through overall mind and body fitness.
Contacts:
| Media: Unnikrishnan M Corporate Communications Officer Burjeel Holdings krish@burjeelholdings.com M: +971 50 427 5895 | Investor Relations: Chetan Sehgal Head of Investor Relations Burjeel Holdings ir@burjeelholdings.com M: +971 56 682 0515 |
Read Full Story: GulfNews | albayan | alkhaleej | mid-east.info | gccbusinessnews | KhaleejTimes
Burjeel Holdings Joins Hands with France’s IFEM Endo to Provide Specialized Care to Women
The institute will establish a center of excellence for minimally invasive surgeries for endometriosis at the clinic in Burjeel Medical City
Abu Dhabi: In line with its objective to provide world-class care to women and boost medical tourism in the UAE, Burjeel Holdings has joined hands with the globally renowned Franco-European Multidisciplinary Institute of Endometriosis Academy (IFEM Endo) to start a specialized clinic in the country. As part of a Memorandum of Understanding (MoU) signed between the French institute and Burjeel Holdings, one of the largest healthcare service providers in the MENA region, the IFEM Endo Middle East Clinic will be established at Abu Dhabi’s Burjeel Medical City (BMC). The clinic set up at BMC will be a center of excellence for endometriosis and offer highly-advanced minimally invasive surgeries for endometriosis.
The clinic will have a cohesive team approach with multidisciplinary care and highly skilled surgeons. It will serve as a central referral receiving station for the UAE and GCC and will also enable endometriosis research and publications, as well as the establishment of the Emirates Endometriosis Support Club.
Prof. Horace Roman, Consultant – Obstetrics and Gynecology and Founding member of IFEM Endo, will lead a team of doctors to organize the diagnosis and the multidisciplinary management of the disease as well as the management of pain using the model they apply at the clinic in France. The team also consists of Dr. Benjamin Merlot, Consultant – Obstetrics and Gynecology and Founding member of IFEM Endo, Prof. Quentin Denost, Colorectal and Pelvic Surgery at the Bordeaux Colorectal Institute, Dr. Sandesh Kade Specialist – Obstetrics and Gynecology, and Dr. Monica Chauhan, Specialist – Obstetrics & Gynecology. The clinic will work with a holistic approach to managing endometriosis and will have a multidisciplinary team also comprising general surgeons, urologists, pain management specialists, physiotherapists, and gynecologists.
BMC is a leading quaternary care facility equipped with cutting-edge medical technology and employs Western-board-certified physicians.
“We are excited at the opening of the IFEM Endo Clinic at BMC in Abu Dhabi. This clinic is a testament to the team’s commitment and dedication to providing the best endometriosis care possible. I look forward to seeing the positive impact this clinic will have on the lives of patients in the UAE and beyond. I am confident the clinic will play an important role in improving healthcare standards in the UAE and be a source of medical excellence in the region,” said Prof. Roman.
The IFEM Endo Middle East Clinic will provide exclusive and state-of-the-art treatments for adolescent endometriosis, reproductive age endometriosis, endometriosis and fertility, endometriosis and pain. The team will also offer advanced endometriosis surgery and robotic-assisted laparoscopic surgery according to the needs of patients.
According to Mr. John Sunil, CEO of Burjeel Holdings, the partnership is yet another contribution by the Group in promoting Abu Dhabi as a life sciences and medical tourism hub and will boost endometriosis research.
“At Burjeel Holdings, we are committed to providing quality healthcare services to our patients and believe that the launch of IFEM Endo Middle East Clinic is a major step forward in achieving this goal. The new clinic will help patients access advanced medical care and enable them to receive the treatment they need in the most convenient and cost-effective way. The clinic will also strengthen our capabilities in endometriosis research and pave the path for more publications, increasing the potential for a significant future impact on local and global outcomes,” said Mr. Sunil.
The comprehensive Obstetrics and Gynecology Department at BMC will provide the necessary services to support IFEM Endo Middle East Clinic.
[ENDS]
